Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
There Is Something for Everyone to Do to Improve Health Equity, Says Oncology Consultants’ Wagner
March 22nd 2023Many people believe health equity is such a big issue that there is not much an individual practice can do to address it, explained Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy, Oncology Consultants of Houston.
Read More
Pediatric Patients See Benefit in Short-, Long-term Treatment for AD
March 22nd 2023Data from the LIBERTY AD PRESCHOOL trial, and its ongoing open-label extension analysis show that dupilumab is safe and clinically effective, and can lead to statistically significant symptom improvement among patients aged 6 months to 17 years who have moderate to severe atopic dermatitis (AD).
Read More
Dr Tochi Okwuosa: Baseline Risk Assessment of Heart Function Necessary in Cancer Care
March 21st 2023Baseline risk assessment that includes prior treatment history for cancer, prior cardiovascular events, and markers for potential heart damage are all important, emphasizes Tochi M. Okwuosa, DO, cardiologist and director of cardio-oncology at Rush University Medical Center in Chicago.
Read More
Patient Outcomes Improve on Several Fronts Following Treatment for Prurigo Nodularis
March 20th 2023Subanalyses of data from the LIBERTY PN-PRIME and LIBERTY PN-PRIME2 studies illustrate how dupilumab for prurigo nodularis can better patient outcomes, including quality of life and symptom burden.
Read More
Patients With AD May Have Greater Risk of Certain Malignancies
March 17th 2023Investigators of this study noted the need for more data on risks of malignancies among patients who have atopic dermatitis (AD), with the chronic skin condition already having significant associations with nonmelanoma skin cancer, lymphoma, keratinocyte carcinoma, and pancreatic and kidney cancers.
Read More
Trio of Scales Deemed Valid, Reliable for Use in Prurigo Nodularis
March 16th 2023The Skin Pain Numeric Rating Scale, Worst-Itch Numeric Rating Scale, and Dermatology Life Quality Index were evaluated for their content validity, fit-for-purpose, and psychometric and measurement properties among patients with the chronic skin disease being treated with dupilumab.
Read More
Dr David Eagle on Celebrating 20 Years of COA at This Year’s Meeting
March 15th 2023In this preview of the 2023 Community Oncology Conference, past president of the Community Oncology Alliance, David Eagle, MD, of New York Cancer & Blood Specialists, discusses what has him excited for this year's meeting, both sessions and speakers.
Read More
Highlands Oncology Group’s Jeff Hunnicutt Discusses Risk Under the EOM
March 10th 2023Jeff Hunnicutt, CEO of Highlands Oncology Group, explains the 2 risk options provided under the Enhancing Oncology Model (EOM) and why the mandatory downside risk might give pause to practices that saw some success in the Oncology Care Model.
Read More
Dr Sigrun Hallmeyer Discusses Use of Precision Medicine in the First-line Setting
March 10th 2023As scientists are identifying molecular alterations in patients with later-stage cancers that may be targets in earlier-stage disease, next-generation sequencing is being utilized more in the first-line setting, noted Sigrun Hallmeyer, MD, medical oncologist with Advocate Health.
Read More
Dr Kevin Davies: There Is Great Potential for CRISPR in Genetic Diseases and Cancers
March 9th 2023Kevin Davies, PhD, executive editor, The CRISPR Journal and GEN Biotechnology, discusses how CRISPR has evolved from the initial discovery of the double helix to now, with the technology holding great promise for both genetic diseases and cancers.
Read More
Dr Andre Harvin: Pharmacists Play a Critical Role in Oncology Care
March 9th 2023Andre Harvin, PharmD, MS, MBA, Cone Health Cancer Center, discusses the vital role of pharmacists in oncology: how they use data to streamline patient visits, work to facilitate patient access to biosimilars, and advocate for their patients.
Read More
FDA Accepts Application for Dupilumab to Treat Chronic Spontaneous Urticaria
March 7th 2023The supplemental Biologics License Application was filed for the new indication for dupilumab, which is already approved to treat atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, and eosinophilic esophagitis.
Read More
Dr Olalekan Ajayi Previews the 2023 ACCC Annual Meeting
March 6th 2023Olalekan Ajayi, PharmD, MBA, chief operating officer of Highlands Oncology Group, PA, and 2023-2024 president-elect of the Association of Community Cancer Centers (ACCC), discusses why he is excited for this year’s meeting, including its many workshops and day 1 keynote on CRISPR.
Read More
Dr Sashi Naidu: Partnering With Molecular Diagnostic Labs Facilitates Advanced Cancer Care
March 6th 2023Carolina Blood and Cancer Care Associates’ No One Left Alone initiative works to dismantle cancer health disparities and increase health care equity among its rural patient population. Sashi Naidu, MD, director of research, discusses delivering next-generation sequencing testing to patients.
Read More
Dr Deepak Bhatt Discusses Results From the ENTRIGUE Trial
March 2nd 2023Deepak L. Bhatt, MD, MPH, Icahn School of Medicine at Mount Sinai, has multiple presentations during the upcoming American College of Cardiology Scientific Sessions, including additional phase 2 results from the ENTRIGUE trial for pegozafermin in severe hypertriglyceridemia.
Read More
Dr Stephen Schleicher: We’re at a Turning Point in Oncology Care
March 2nd 2023Stephen M. Schleicher, MD, MBA, chief medical officer at Tennessee Oncology, discusses the present state of value-based oncology care and what the future may bring when the Enhancing Oncology Model kicks off on July 1.
Read More
Comparable Results Seen From Investigation of Torsemide vs Furosemide in HF
February 28th 2023Outcomes from the loop diuretics were compared in this analysis, with study participants from the TRANSFORM-HF trial matched 1:1, all having been hospitalized for either do novo disease or worsening chronic disease.
Read More
Telehealth Involves More Than Making a Phone Call, Says Oncology Consultants’ Wagner
February 19th 2023We’ve found through health equity initiatives that the search for the right telehealth modality is never ending, explained Oncology Consultants of Houston’s Susan Sabo-Wagner, MSN, RN, OCN, executive director of clinical strategy.
Read More
Dr Sashi Naidu: NOLA Initiative Is Helping Overcome Fragmented Oncology Care
February 17th 2023At Carolina Blood and Cancer Care Associates, the No One Left Alone (NOLA) initiative is working to break down cancer health disparities among its patients by addressing the social determinants of health that may be preventing equitable access to care.
Read More